Akeso
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Akeso
RECRUITINGPhase 2NCT07114315
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
This is an open-label, multi-center phase II clinical study consisting of two parts: Part I: To evaluate the safety and efficacy of AK130 combined with AK112 in advanced...
Sponsor: AkesoEnrolling: 1602 locations
Pancreatic Cancer
RECRUITINGPhase 2NCT06686030
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
An Exploratory, Multi-cohort Phase II Study of combination therapy of AK112 with chemotherapy and/or olaparib in platinum-sensitive ovarian cancer(PSOC)
Sponsor: AkesoEnrolling: 1501 location
Platinum-sensitive Ovarian Cancer